Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
More definitive answers about the death of a woman in an adeno-associated virus (AAV) gene therapy trial for arthritis must await a meeting of the Recombinant DNA Advisory Committee (RAC) later this month.
To what extent did the French government's failure to publicly disclose the exact location of field trials contribute to the suicide of a farmer hounded by anti-GM activists?
Recombinant technology has not yet taken root in ornamental plant breeding, but if some early genetically modified products succeed in the marketplace, might this change?
An unprecedented study claiming that transgenic soybeans compromise the fertility of rats and the survival and growth of their offspring has garnered widespread media and political attention but remains unpublished in the peer-reviewed literature. Here, an account of the work from the principal investigator, Irina Ermakova, is appended with comments from researchers in the field.
As genetic testing moves into mainstream medicine, its restriction by gene patent holders will have far-reaching, detrimental effects on the healthcare system.